Options: Show MedDRA Preferred Terms
| Side effect | Data for drug | Placebo | Labels | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | |||
| Application site irritation | 2.68% - 3.7% | x | ||||||||
| Application site dryness | 2.68% - 5.19% | x | ||||||||
| Application site pruritus | 2% - 3.7% | x | ||||||||
| Cushing's syndrome | x | |||||||||
| Folliculitis | x | x | x | x | x | x | x | x | ||
| Glycosuria | x | |||||||||
| Hyperglycaemia | x | |||||||||
| Hypertrichosis | x | x | x | x | x | x | x | |||
| Miliaria | x | x | x | x | x | x | x | |||
| Pruritus | x | x | x | x | x | x | x | |||
| Pyoderma | x | |||||||||
| Pigmentation skin | x | |||||||||
| Telangiectasia | x | |||||||||
| Erythema | x | x | x | x | ||||||
| Burning sensation | x | x | x | x | x | |||||
| Skin atrophy | x | x | x | x | x | x | x | |||
| Skin striae | x | x | x | x | x | x | x | |||
| Allergic contact dermatitis | x | x | x | x | x | x | ||||
| Leukoderma | x | x | x | x | x | x | ||||
| Acneiform eruption | x | x | x | x | x | x | ||||
| Comedone | x | |||||||||
| Cataract subcapsular | x | |||||||||
| Dermatitis perioral | x | x | x | x | x | x | ||||
| Secondary adrenocortical insufficiency | x | |||||||||
| Plaque psoriasis | x | |||||||||
| Secondary infection | x | x | x | x | x | x | x | |||
| Stinging | x | x | ||||||||
Information about indications was extracted from the indications and usage sections of the labels.
| Indication | Labels | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Skin disorder | x | x | x | x | x | x | x | |||
standard – alternative
| 100% | ||
| 75% | ||
| 50% | ||
| 10% | ||
| frequent (1% to 100%) | ||
| infrequent (0.1% to 1%) | ||
| rare (<0.1%) | ||
| postmarketing | ||
| 0% | ||
| no frequency information | ||
| not found on label |